Animal models of obsessive compulsive disorder: recent findings and future directions. 2011

Kurt Leroy Hoffman
Centro de Investigación en Reproducción Animal , Universidad Autónoma de Tlaxcala - CINVESTAV, Tlaxcala , México , 90000 rexvitro@hotmail.com.

BACKGROUND Obsessive compulsive disorder (OCD) is a debilitating condition with limited treatment options. OCD is heterogeneous with respect to the content of obsessions and compulsions and their underlying motivation, among other characteristics. Animal models have provided important insights into the pathophysiology of OCD. METHODS The phenomenology of OCD is discussed, with emphasis on clinically-relevant subgroups. The paper also discusses the advantages and limitations of animals as models of OCD, along with considerations on assessing their validity. A PubMed database search using the terms 'animal model' and 'obsessive compulsive disorder' revealed ongoing studies in several models, including stereotypy in the deer mouse, quinpirole-induced checking, spontaneous alternation, compulsive lever pressing, genetic models, pathogenic models and models involving normal compulsive-like behavioral patterns. These models are presented with respect to their similarity to specific features of OCD and the information gained from them. Studies in many of these models point to the participation of corticostriatal thalamocortical circuitry and corticostriatal glutamate neurotransmission in the pathophysiology of compulsive-like behavior. CONCLUSIONS The use of animal models takes us beyond simple serotonin- or dopamine-based models of OCD that are founded on the often limited, and still unexplained, response of OCD symptoms to serotonin reuptake inhibitors or antipsychotic therapy. Pharmacological challenges that selectively target neurochemical systems that modulate either corticostriatal glutamate or striatal dopamine neurotransmission, or indeed both, should be investigated in animal models of compulsive-like behavior. Such systems include metabotropic glutamate, adenosine and endocannabinoid receptors, among others.

UI MeSH Term Description Entries

Related Publications

Kurt Leroy Hoffman
January 1992, Clinical neuropharmacology,
Kurt Leroy Hoffman
October 2008, Current protocols in neuroscience,
Kurt Leroy Hoffman
May 2011, Biological psychiatry,
Kurt Leroy Hoffman
January 2022, Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999),
Kurt Leroy Hoffman
June 1992, International clinical psychopharmacology,
Kurt Leroy Hoffman
February 2011, Expert review of neurotherapeutics,
Kurt Leroy Hoffman
February 2019, Journal of cognitive psychotherapy,
Kurt Leroy Hoffman
May 2017, Neuroscience and biobehavioral reviews,
Copied contents to your clipboard!